CoinVoice has learned that, according to strategic transformation information led by Titan Partners Group and the encryption investment company GSR, the American pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing its establishment of a dedicated Litecoin treasury strategy. Currently, over 100 million dollars in funding commitments have been made for this project.



It is worth mentioning that Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

In addition, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy aligns closely with the core mission of the Litecoin Foundation to promote global adoption of Litecoin.
TITAN-0.53%
LTC2.31%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)